-
How I treat multiple myeloma in younger patients Stewart AK, Richardson PG, San Miguel JF. Blood 114(27):5436-43. FI: 10.555 (Q1) How to treat a newly diagnosed young patient with multiple myeloma San Miguel JF, Mateos MV. Hematology 555-65. FI: 1.333 (Q4) IMWG. International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100) Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger W, Comenzo RL, Kumar S, Munshi NC, Dispenzieri A, Kyle R, Merlini G, San Miguel JF, Ludwig H, Hajek R, Jagannath S, Blade J, Lonial S, Dimopoulos MA, Einsele H, Barlogie B, Anderson KC, Gertz M, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Richardson PG, Niesvizky R, Rajkumar SV, Durie BG. Leukemia 23(10):1904-12. FI: 8.296 (Q1) IMWG.International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation Palumbo A, Sezer O, Kyle R, Miguel JS, Orlowski RZ, Moreau P, Niesvizky R, Morgan G, Comenzo R, Sonneveld P, Kumar S, Hajek R, Giralt S, Bringhen S, Anderson KC, Richardson PG, Cavo M, Davies F, Bladé J, Einsele H, Dimopoulos MA, Spencer A, Dispenzieri A, Reiman T, Shimizu K, Lee JH, Attal M, Boccadoro M, Mateos M, Chen W, Ludwig H, Joshua D, Chim J, Hungria V, Turesson I, Durie BG, Lonial S Leukemia 23(10):1716-30. FI: 8.296 (Q1) International Myeloma Working group guidelines for serum¿free light chain analysis in multiple myeloma and related disorder Dispenzieri A, Kyle R, Merlini G, San Miguel JF, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseay JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG.International Myeloma Working group Leukemia 23(2):215-24. FI: 8.296 (Q1) International myeloma working group guidelines for serum-free light chain analysis in multiple myeloma and related disorders Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG. International Myeloma Working Group Leukemia 23(2):215-24. FI: 8.296 (Q1) International prognostic scoring system for Waldenstrom's macroglobulinemia Morel P, Duhamel A, Gobbi P, Dimopoulos MA, Dhodapkar MV, McCoy J, Crowley J, Ocio EM, Garcia-Sanz R, Treon SP, Leblond V, Kyle RA, Barlogie B, Merlini G. Blood 113(18):4163-70. FI: 10.555 (Q1) Lenalidomide in combination with dexamethaosne at first relapse in combination with its use as later salvage therapy in relapsed or refractory multiple myeloma Stadtmauer EA, Weber DM, Niesvizky R, Belch A, Prince MH, San Miguel JF, Facon T, Olesnyckyj M, Yu Z, Zeldis JB, Knight RD, Dimopoulos MA. European Journal of Haematology 82(6):426-32. FI: 2.345 (Q3) Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma Palumbo A, Dimopoulos M, San Miguel JF, Harousseau JL, Attal M, Hussein M, Knop S, Ludwig H, von Lilienfeld-Toal M, Sonneveld P. Blood Reviews 23(2):87-93. FI: 7.185 (Q1) Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with dose from normal donors Garayoa M, García JL, Santamaría C, García-Gómez A, Blanco JF, Pandiella A, Hernández JM, Sánchez-Guijo FM, Del Cañizo MC, Gutierrez NC, San Miguel JF. Leukemia 23(8):1515-27. FI: 8.296 (Q1)
|
